Methylglucamine orotate, a memory-improving drug, prolongs hippocampal long-term potentiation

Eur J Pharmacol. 1989 Dec 7;173(2-3):223-6. doi: 10.1016/0014-2999(89)90526-8.

Abstract

We showed earlier that the memory-improving substance, methylglucamine orotate, a precursor of pyrimidine nucleotide synthesis, improved memory retention and enhanced the postconditioning potentiation of field potentials in a special learning task. Since long-term potentiation (LTP) is frequently regarded as a mechanism of memory formation, we decided to test whether it can be influenced in a similar manner. The present study shows that the same dose of methylglucamine orotate (225 micrograms i.c.v.) prolongs LTP but has only a slight effect on the field potential recorded in the dentate gyrus. In controls, LTP of the population spike returned to 154% of the control value 24 h after tetanization and to 126% after 48 h. However, in drug treated animals LTP of the population spike remained at 246 and 216% of the control, respectively. The results support the assumption that LTP is at least a component of memory formation.

MeSH terms

  • Animals
  • Evoked Potentials / drug effects
  • Hippocampus / drug effects*
  • Injections, Intraventricular
  • Male
  • Meglumine / analogs & derivatives*
  • Meglumine / pharmacology
  • Memory / drug effects*
  • Orotic Acid / analogs & derivatives*
  • Orotic Acid / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Sorbitol / analogs & derivatives*

Substances

  • Sorbitol
  • methylglucamine orotate
  • Orotic Acid
  • Meglumine